WELLS FARGO & COMPANY/MN - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAC0. A total of 9 filers reported holding ACORDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,424,785
-15.1%
5,018,0000.0%0.00%0.0%
Q2 2023$4,031,963
+28.4%
5,018,0000.0%0.00%0.0%
Q1 2023$3,140,465
-1.1%
5,018,0000.0%0.00%0.0%
Q4 2022$3,174,387
-16.4%
5,018,0000.0%0.00%0.0%
Q3 2022$3,796,000
-0.5%
5,018,0000.0%0.00%0.0%
Q2 2022$3,814,000
+0.3%
5,018,0000.0%0.00%0.0%
Q1 2022$3,801,000
-1.6%
5,018,0000.0%0.00%0.0%
Q4 2021$3,864,000
-2.6%
5,018,0000.0%0.00%0.0%
Q3 2021$3,969,000
+10.0%
5,018,0000.0%0.00%0.0%
Q2 2021$3,607,000
+2.7%
5,018,0000.0%0.00%0.0%
Q1 2021$3,511,0005,018,0000.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 25,875,000$19,021,0001.51%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 45,283,000$34,415,0000.78%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 52,324,000$38,202,0000.66%
UBS OCONNOR LLC 30,000,000$22,523,000,0000.33%
Soros Fund Management 28,001,000$16,213,0000.29%
Saltoro Capital, LP 1,500,000$1,110,0000.27%
D. E. Shaw & Co., Inc. 14,000,000$10,435,0000.01%
WELLS FARGO & COMPANY/MN 5,018,000$3,814,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACORDA THERAPEUTICS INC shareholders